159 related articles for article (PubMed ID: 37480413)
1. Catalpol Prevents Glomerular Angiogenesis Induced by Advanced Glycation End Products via Inhibiting Galectin-3.
Sun WX; Gao YY; Cao Y; Lu JF; Lv GH; Xu HQ
Curr Med Sci; 2023 Aug; 43(4):668-678. PubMed ID: 37480413
[TBL] [Abstract][Full Text] [Related]
2. Catalpol ameliorates endothelial dysfunction and inflammation in diabetic nephropathy via suppression of RAGE/RhoA/ROCK signaling pathway.
Shu A; Du Q; Chen J; Gao Y; Zhu Y; Lv G; Lu J; Chen Y; Xu H
Chem Biol Interact; 2021 Oct; 348():109625. PubMed ID: 34416245
[TBL] [Abstract][Full Text] [Related]
3. Catalpol ameliorates advanced glycation end product-induced dysfunction of glomerular endothelial cells via regulating nitric oxide synthesis by inducible nitric oxide synthase and endothelial nitric oxide synthase.
Sun W; Gao Y; Ding Y; Cao Y; Chen J; Lv G; Lu J; Yu B; Peng M; Xu H; Sun Y
IUBMB Life; 2019 Sep; 71(9):1268-1283. PubMed ID: 30861639
[TBL] [Abstract][Full Text] [Related]
4. Catalpol protects vascular structure and promotes angiogenesis in cerebral ischemic rats by targeting HIF-1α/VEGF.
Wang H; Xu X; Yin Y; Yu S; Ren H; Xue Q; Xu X
Phytomedicine; 2020 Nov; 78():153300. PubMed ID: 32866905
[TBL] [Abstract][Full Text] [Related]
5. Catalpol suppressed proliferation, growth and invasion of CT26 colon cancer by inhibiting inflammation and tumor angiogenesis.
Zhu P; Wu Y; Yang A; Fu X; Mao M; Liu Z
Biomed Pharmacother; 2017 Nov; 95():68-76. PubMed ID: 28826099
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of catalpol on diabetes mellitus-induced male reproductive damage via suppression of the AGEs/RAGE/Nox4 signaling pathway.
Jiao N; Chen Y; Zhu Y; Wang W; Liu M; Ding W; Lv G; Lu J; Yu B; Xu H
Life Sci; 2020 Sep; 256():116736. PubMed ID: 31398417
[TBL] [Abstract][Full Text] [Related]
7. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
[TBL] [Abstract][Full Text] [Related]
8. Genipin ameliorates diabetic retinopathy via the HIF-1α and AGEs-RAGE pathways.
Sun K; Chen Y; Zheng S; Wan W; Hu K
Phytomedicine; 2024 Jul; 129():155596. PubMed ID: 38626646
[TBL] [Abstract][Full Text] [Related]
9. Loganin and catalpol exert cooperative ameliorating effects on podocyte apoptosis upon diabetic nephropathy by targeting AGEs-RAGE signaling.
Chen Y; Chen J; Jiang M; Fu Y; Zhu Y; Jiao N; Liu L; Du Q; Wu H; Xu H; Sun J
Life Sci; 2020 Jul; 252():117653. PubMed ID: 32277978
[TBL] [Abstract][Full Text] [Related]
10. Effect of catalpol on diabetic nephropathy in rats.
Dong Z; Chen CX
Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
[TBL] [Abstract][Full Text] [Related]
11. Anthocyanin-rich purple corn extract inhibit diabetes-associated glomerular angiogenesis.
Kang MK; Lim SS; Lee JY; Yeo KM; Kang YH
PLoS One; 2013; 8(11):e79823. PubMed ID: 24278186
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
[TBL] [Abstract][Full Text] [Related]
13. [Effect of Cordyceps sinensis on expressions of HIF-1α and VEGF in the kidney of rats with diabetic nephropathy].
Yuan M; Tang R; Zhou Q; Liu K; Xiao Z; Pouranan V
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 May; 38(5):448-57. PubMed ID: 23719521
[TBL] [Abstract][Full Text] [Related]
14. Catalpol attenuates ischemic stroke by promoting neurogenesis and angiogenesis via the SDF-1α/CXCR4 pathway.
Zhang MF; Wang JH; Sun S; Xu YT; Wan D; Feng S; Tian Z; Zhu HF
Phytomedicine; 2024 Jun; 128():155362. PubMed ID: 38522312
[TBL] [Abstract][Full Text] [Related]
15. Catalpol Inhibits Homocysteine-induced Oxidation and Inflammation via Inhibiting Nox4/NF-κB and GRP78/PERK Pathways in Human Aorta Endothelial Cells.
Hu H; Wang C; Jin Y; Meng Q; Liu Q; Liu Z; Liu K; Liu X; Sun H
Inflammation; 2019 Feb; 42(1):64-80. PubMed ID: 30315526
[TBL] [Abstract][Full Text] [Related]
16. Swertiamarin mitigates nephropathy in high-fat diet/streptozotocin-induced diabetic rats by inhibiting the formation of advanced glycation end products.
Parwani K; Patel F; Bhagwat P; Dilip H; Patel D; Thiruvenkatam V; Mandal P
Arch Physiol Biochem; 2024 Apr; 130(2):136-154. PubMed ID: 34657540
[TBL] [Abstract][Full Text] [Related]
17. Catalpol suppresses advanced glycation end-products-induced inflammatory responses through inhibition of reactive oxygen species in human monocytic THP-1 cells.
Choi HJ; Jang HJ; Chung TW; Jeong SI; Cha J; Choi JY; Han CW; Jang YS; Joo M; Jeong HS; Ha KT
Fitoterapia; 2013 Apr; 86():19-28. PubMed ID: 23376161
[TBL] [Abstract][Full Text] [Related]
18. Catalpol Alleviates Ang II-Induced Renal Injury Through NF-κB Pathway and TGF-β1/Smads Pathway.
Cong C; Yuan X; Hu Y; Chen W; Wang Y; Tao L
J Cardiovasc Pharmacol; 2022 Jan; 79(1):e116-e121. PubMed ID: 34654783
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products accelerate calcification in VSMCs through HIF-1α/PDK4 activation and suppress glucose metabolism.
Zhu Y; Ma WQ; Han XQ; Wang Y; Wang X; Liu NF
Sci Rep; 2018 Sep; 8(1):13730. PubMed ID: 30213959
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic effects of catalpol on rat corneal neovascularization.
Han Y; Shen M; Tang LY; Tan G; Yang QC; Ye L; Ye LH; Jiang N; Gao GP; Shao Y
Mol Med Rep; 2018 Feb; 17(2):2187-2194. PubMed ID: 29207076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
